GlassScriptPhysician profile
Samantha Naples
NPI 1750868543
$3,631.07
in general payments reported to CMS, 2019-2025
21 companies · $1,031 in 2025
The $1,031 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $170 · 2023: $729 · 2024: $1,701 · 2025: $1,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,460.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $643.76 | 2022-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $486.62 | 2023-2025 | |
| Amgen INC. | $309.05 | 2022-2025 | Repatha, Repatha |
| Atricure, INC. | $280.02 | 2023-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $218.10 | 2024 | Arcalyst |
| Pfizer INC. | $198.23 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $180.91 | 2024 | Xarelto |
| Abbott Laboratories | $167.89 | 2024-2025 | Cardiomems, Mitraclip |
| Bridgebio Pharma, INC. | $151.20 | 2025 | Attruby |
| Boston Scientific Corporation | $145.85 | 2023 | Ingevity Mri |
| E.R. Squibb & Sons, L.L.C. | $144.46 | 2023-2025 | Eliquis, Camzyos |
| Esperion Therapeutics, INC. | $141.31 | 2023-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.92 | 2024-2025 | Lifevest |
| Agepha Pharma Fz LLC | $99.21 | 2025 | Lodoco |
| Zoll Respicardia, INC. | $74.80 | 2023 | Remede System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $65.00 | 2024 | Verquvo |
| Inspire Medical Systems, INC. | $51.63 | 2024 | Inspire |
| Kestra Medical Technology Services, INC. | $43.42 | 2024-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals, LTD. | $42.78 | 2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $24.03 | 2025 | Onpattro |
| Novo Nordisk INC | $22.88 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Naples listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.